SureSelect Cancer CGP Assay
Comprehensive genomic profiling of solid tumors to detect key classes of somatic alterations.
- Globally curated gene content (679 genes for DNA, 80 genes for RNA) sourced from cancer databases and leading clinical cancer researchers
- Improved lab efficiency with automation, including the benchtop Agilent Magnis NGS Prep system that requires minimal expertise and only 15 minutes of hands-on time for walkaway convenience and the Agilent Bravo NGS workstation, a liquid handling platform for scaling up to 96 samples per run
- Enzymatic fragmentation option eliminates the need for physical shearing equipment
- Start with input as low as 10 ng DNA (recommended 50 ng) to enable profiling of more samples
- Fast hybridization (90 minutes) for library preparation in a single day
- Detection of de novo gene fusions (80 genes) requiring only one gene partner
- Developed for multiple sample types including FFPE
- Modular workflow allows the option to assay DNA and RNA separately or together in the same sequencing run
- Integrated data analysis with Agilent Alissa Clinical Informatics Platform. Also compatible with customer in-house informatics and 3rd party analysis software